2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BOHLENDER, J. Articles by LUFT, F. C. Search for Related Content PubMed PubMed Citation Articles by BOHLENDER, J. Articles by LUFT, F. C.

Rats Transgenic for Human Renin and Human Angiotensinogen as a Model for Gestational Hypertension

JÜRGEN BOHLENDER^*,, DETLEV GANTEN^, and FRIEDRICH C. LUFT^*,

^* Franz Volhard Clinic, Berlin, Germany.
Max Delbrück Center, Medical Faculty of the Charié, Humboldt University of Berlin, Berlin, Germany.
Department of Clinical Pharmacology, Klinikum Benjamin Franklin, Free University of Berlin, Berlin, Germany.

Correspondence to Dr. Friedrich C. Luft, Charité Campus-Buch, Franz Volhard Clinic, Wiltberg Strasse 50, 13125 Berlin, Germany. Phone: 0049 30 9417 2202; Fax: 0049 30 9417 2206; E-mail: luft{at}fvk-berlin.de

Abstract. Animal models of gestational hypertension are problematic. A novel mouse model was described earlier. The dams in that study were transgenic for human angiotensinogen and the sires for human renin; human renin was expressed in and produced by the placenta. This model was adapted to the rat, which has greater utility in terms of chronic instrumentation and physiologic measurements. Female rats transgenic for human angiotensinogen were mated with rats transgenic for human renin. Telemetry BP increased on day 5 of pregnancy from 110/80 mmHg to as high as 180/140 mmHg, while heart rate increased slightly. The renin transgene was expressed in the placenta, which resulted in increased human plasma renin concentration from 0 to 937 ± 800 ng angiotensin I ml/h; the values returned to 0 after delivery. Female rats transgenic for human renin that were mated with male rats transgenic for human angiotensinogen in contrast exhibited a decrease in BP. In these rats, human angiotensinogen in plasma remained undetectable. Double transgenic offspring of these transgenic rats developed hypertension and end-organ damage, regardless of the source of the transgenes. The conclusion is that transgenic rats that bear human renin and angiotensinogen genes make an attractive model for gestational hypertension. The rat model will have greater utility than the mouse model.

This article has been cited by other articles:

				L. Hering, F. Herse, S. Verlohren, J.-K. Park, M. Wellner, F. Qadri, R. Pijnenborg, A. C. Staff, B. Huppertz, D. N. Muller, et al. Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response Hypertension, February 1, 2008; 51(2): 554 - 559. [Abstract] [Full Text] [PDF]

				S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al. Uterine Vascular Function in a Transgenic Preeclampsia Rat Model Hypertension, February 1, 2008; 51(2): 547 - 553. [Abstract] [Full Text] [PDF]

				R. Dechend, V. Homuth, G. Wallukat, D. N. Muller, M. Krause, J. Dudenhausen, H. Haller, and F. C. Luft Agonistic Antibodies Directed at the Angiotensin II, AT1 Receptor in Preeclampsia Reproductive Sciences, February 1, 2006; 13(2): 79 - 86. [Abstract] [PDF]

				S. Sethi, S. Iida, C. D. Sigmund, and D. D. Heistad Renal Thrombotic Microangiopathy in a Genetic Model of Hypertension in Mice Experimental Biology and Medicine, February 1, 2006; 231(2): 196 - 203. [Abstract] [Full Text] [PDF]

				J. Lazar, C. Moreno, H. J. Jacob, and A. E. Kwitek Impact of genomics on research in the rat Genome Res., December 1, 2005; 15(12): 1717 - 1728. [Abstract] [Full Text] [PDF]

				E. Takimoto-Ohnishi, T. Saito, J. Ishida, J. Ohnishi, F. Sugiyama, K.-I. Yagami, and A. Fukamizu Differential Roles of Renin and Angiotensinogen in the Feto-Maternal Interface in the Development of Complications of Pregnancy Mol. Endocrinol., May 1, 2005; 19(5): 1361 - 1372. [Abstract] [Full Text] [PDF]

				R. Dechend, P. Gratze, G. Wallukat, E. Shagdarsuren, R. Plehm, J.-H. Brasen, A. Fiebeler, W. Schneider, S. Caluwaerts, L. Vercruysse, et al. Agonistic Autoantibodies to the AT1 Receptor in a Transgenic Rat Model of Preeclampsia Hypertension, April 1, 2005; 45(4): 742 - 746. [Abstract] [Full Text] [PDF]

				J. M. Davison, V. Homuth, A. Jeyabalan, K. P. Conrad, S. A. Karumanchi, S. Quaggin, R. Dechend, and F. C. Luft New Aspects in the Pathophysiology of Preeclampsia J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2440 - 2448. [Abstract] [Full Text] [PDF]

				A. Beausejour, K. Auger, J. St-Louis, and M. Brochu High-sodium intake prevents pregnancy-induced decrease of blood pressure in the rat Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H375 - H383. [Abstract] [Full Text] [PDF]

				Y. Xia, H. Wen, H. R. Prashner, R. Chen, T. Inagami, D. F. Catanzaro, and R. E. Kellems Pregnancy-Induced Changes in Renin Gene Expression in Mice Biol Reprod, January 1, 2002; 66(1): 135 - 143. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673